SE0800272L - Växtsterolkompositioner med förhöjd biotillgänglighet - Google Patents

Växtsterolkompositioner med förhöjd biotillgänglighet

Info

Publication number
SE0800272L
SE0800272L SE0800272A SE0800272A SE0800272L SE 0800272 L SE0800272 L SE 0800272L SE 0800272 A SE0800272 A SE 0800272A SE 0800272 A SE0800272 A SE 0800272A SE 0800272 L SE0800272 L SE 0800272L
Authority
SE
Sweden
Prior art keywords
preparing
phytosterol
plant sterol
increased bioavailability
porous
Prior art date
Application number
SE0800272A
Other languages
English (en)
Other versions
SE0800272A1 (sv
SE532965C2 (sv
Inventor
Sergej Bolkhovets
Atte J Kumpulainen
Original Assignee
Edio Healthcare Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40568520&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0800272(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of SE0800272A1 publication Critical patent/SE0800272A1/sv
Application filed by Edio Healthcare Ab filed Critical Edio Healthcare Ab
Priority to SE0800272A priority Critical patent/SE532965C2/sv
Priority to RU2010136984/13A priority patent/RU2485808C2/ru
Priority to ES09708508.8T priority patent/ES2532013T3/es
Priority to PL09708508T priority patent/PL2278890T3/pl
Priority to PCT/SE2009/050127 priority patent/WO2009099392A1/en
Priority to DK09708508.8T priority patent/DK2278890T3/en
Priority to CA2713380A priority patent/CA2713380C/en
Priority to EP09708508.8A priority patent/EP2278890B1/en
Priority to US12/863,451 priority patent/US9078464B2/en
Publication of SE0800272L publication Critical patent/SE0800272L/sv
Publication of SE532965C2 publication Critical patent/SE532965C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE0800272A 2008-02-06 2008-02-06 Förfarande för framställning av mikropartiklar innehållande växtsterol SE532965C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0800272A SE532965C2 (sv) 2008-02-06 2008-02-06 Förfarande för framställning av mikropartiklar innehållande växtsterol
US12/863,451 US9078464B2 (en) 2008-02-06 2009-02-06 Compositions of phytosterols with enhanced bioavailability
EP09708508.8A EP2278890B1 (en) 2008-02-06 2009-02-06 Compositions of phytosterols with enhanced bioavailability
PL09708508T PL2278890T3 (pl) 2008-02-06 2009-02-06 Kompozycje fitosteroli o zwiększonej dostępności biologicznej
ES09708508.8T ES2532013T3 (es) 2008-02-06 2009-02-06 Composiciones de fitosteroles con biodisponibilidad potenciada
RU2010136984/13A RU2485808C2 (ru) 2008-02-06 2009-02-06 Композиция с фитостеролами повышенной биологической доступности
PCT/SE2009/050127 WO2009099392A1 (en) 2008-02-06 2009-02-06 Compositions of phytosterols with enhanced bioavailability
DK09708508.8T DK2278890T3 (en) 2008-02-06 2009-02-06 COMPOSITIONS OF PHYTOSTEROLS WITH INCREASED BIOTAILABILITY
CA2713380A CA2713380C (en) 2008-02-06 2009-02-06 Compositions of phytosterols with enhanced bioavailability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0800272A SE532965C2 (sv) 2008-02-06 2008-02-06 Förfarande för framställning av mikropartiklar innehållande växtsterol

Publications (3)

Publication Number Publication Date
SE0800272A1 SE0800272A1 (sv)
SE0800272L true SE0800272L (sv) 2009-08-07
SE532965C2 SE532965C2 (sv) 2010-05-25

Family

ID=40568520

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0800272A SE532965C2 (sv) 2008-02-06 2008-02-06 Förfarande för framställning av mikropartiklar innehållande växtsterol

Country Status (9)

Country Link
US (1) US9078464B2 (sv)
EP (1) EP2278890B1 (sv)
CA (1) CA2713380C (sv)
DK (1) DK2278890T3 (sv)
ES (1) ES2532013T3 (sv)
PL (1) PL2278890T3 (sv)
RU (1) RU2485808C2 (sv)
SE (1) SE532965C2 (sv)
WO (1) WO2009099392A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120282368A1 (en) * 2011-05-03 2012-11-08 Brandeis University Amphiphilic sterol/fat-based particles
IT201700066508A1 (it) 2017-06-15 2018-12-15 Isagro Spa Sospensioni concentrate di fitosteroli e relativo processo di preparazione
FR3091706B1 (fr) * 2019-01-10 2021-10-01 Arkema France Composition d’huile végétale pour l’enrobage de particules
CN117837758B (zh) * 2024-03-08 2024-05-28 中国农业大学 一种溶解度提高的无定形植物甾醇及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865939A (en) * 1973-02-23 1975-02-11 Procter & Gamble Edible oils having hypocholesterolemic properties
US6110502A (en) * 1998-02-19 2000-08-29 Mcneil-Ppc, Inc. Method for producing water dispersible sterol formulations
SE512958C2 (sv) 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
US5932562A (en) * 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
AU1460801A (en) 1999-11-04 2001-05-14 Patrick J Kinlen Cholesterol reducing sterol compositions, preparation and method of use
US7144595B2 (en) 2001-11-16 2006-12-05 Brandeis University Prepared foods containing triglyceride-recrystallized non-esterified phytosterols
JP4157765B2 (ja) * 2002-02-18 2008-10-01 花王株式会社 粉末油脂
DE10253111A1 (de) 2002-11-13 2004-05-27 Basf Ag Pulverförmige Phytosterol-Formulierungen
US8968768B2 (en) 2004-03-29 2015-03-03 Wyeth Llc Phytosterol nutritional supplements
US20060234948A1 (en) 2005-04-04 2006-10-19 Empie Mark W Lignan-containing compositions
JP2007029048A (ja) * 2005-07-29 2007-02-08 Weckteck Biotechnology Co Ltd フィトステロールの乳化方法、それによって調製されるエマルション、およびフィトステロール粉末製品
DE102005039835A1 (de) * 2005-08-23 2007-03-01 Cognis Ip Management Gmbh Pulverförmige Sterolformulierungen mit Kolloidbildnern
US20090092727A1 (en) * 2007-10-04 2009-04-09 Daniel Perlman Water-dispersible phytosterol-surfactant conglomerate particles

Also Published As

Publication number Publication date
EP2278890B1 (en) 2014-12-10
CA2713380A1 (en) 2009-08-13
CA2713380C (en) 2016-07-19
SE532965C2 (sv) 2010-05-25
RU2485808C2 (ru) 2013-06-27
EP2278890A1 (en) 2011-02-02
US20100291198A1 (en) 2010-11-18
US9078464B2 (en) 2015-07-14
DK2278890T3 (en) 2015-02-16
WO2009099392A1 (en) 2009-08-13
ES2532013T3 (es) 2015-03-23
RU2010136984A (ru) 2012-03-20
PL2278890T3 (pl) 2015-05-29

Similar Documents

Publication Publication Date Title
DE502007006185D1 (de) Feste enymformulierungen und verfahren zu deren herstellung
SG196810A1 (en) Controlled release pharmaceutical or foodformulation and process for its preparation
MX2011008389A (es) Sal de tipo tosilato de un derivado de 5-pirazolil-2-piridona, util en el tratamiento de la enfermedad pulmonar obstructiva cronica (epoc).
EP2947073A3 (en) Fused ring analogues of anti-fibrotic agents
WO2009031809A3 (en) Method of preparation an inclusion-complex comprising hydrophobic physiological activation material including with cyclodextrin and its use
SI1752443T1 (sl) Nova kristalinična oblika V agomelatina, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo
BRPI0612848A8 (pt) manopartículas de isoflavona e usos das mesmas
TW200700025A (en) Emat quality-improving agent
NZ591660A (en) Solid oil powders
SI2036892T1 (sl) Derivati tetrahidro h benzazepinov postopek za njihovo pripravo in farmacevtski sestavkiki jih vsebujejo
SE0800272L (sv) Växtsterolkompositioner med förhöjd biotillgänglighet
TW200634007A (en) Substituted indoles, compositions containing them, production process and use
TW200711719A (en) Use of 2,3-dihydroxynaphthalene-6-sulfonic acid salts as dispersants
WO2009130604A3 (en) Solid state forms of deferasirox salts and process for the preparation thereof
ZA201007611B (en) Process for the preparation of benzo-used heteroaryl sulfamates and crystalline form of n-(((2s)-6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methylsulfamine
IL227024A (en) The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them
SI1989182T1 (sl) Kristalinična oblika argininske soli perindoprila, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo
NZ590410A (en) A method for preparing a liquid nisin composition for food preservation
GB2480828B (en) Improvements in the preparation of beverage and food products
EP2551266A8 (en) 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof
WO2011055917A3 (ko) 성기능 개선 효과를 나타내는 아르기닌 유도체 또는 이의 염, 이를 포함하는 성기능 개선용 조성물 그리고 이의 제조방법
WO2011063774A3 (en) Pectin complexes of steroids and pharmaceutical compositions based thereon
PL2147915T3 (pl) Nowe cykloalkilowe pochodne benzotiadiazyn, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te związki
BR112012023052A2 (pt) derivados de fitosterol solúveis em água para reduzir colesterol e preparação dos mesmos
MY153904A (en) Method of producing pharmacologically pure crystals

Legal Events

Date Code Title Description
OPRJ Opposition rejected
NUG Patent has lapsed